OOIR: Observatory of International Research

Papers

(The H4-Index of World Psychiatry is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality	455
Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors	245
Validation of the new DSM‐5‐TR criteria for prolonged grief disorder and the PG‐13‐Revised (PG‐13‐R) scale	236
Designing and scaling up integrated youth mental health care	234
Preventive psychiatry: a blueprint for improving the mental health of young people	233
The promise of machine learning in predicting treatment outcomes in psychiatry	227
The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta‐analytic evaluation of recent meta‐analyses	208
The clinical characterization of the patient with primary psychosis aimed at personalization of management	174
Psychotherapies for depression: a network meta‐analysis covering efficacy, acceptability and long‐term outcomes of all main treatment types	167
Risk and protective factors for mental disorders beyond genetics: an evidence‐based atlas	155
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): III. Emotional dysfunction superspectrum	130
Hierarchical models of psychopathology: empirical support, implications, and remaining issues	120
The clinical significance of duration of untreated psychosis: an umbrella review and random‐effects meta‐analysis	119
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): II. Externalizing superspectrum	119
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions	118
Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double‐blind randomized controlled trial	118
An organization‐ and category‐level comparison of diagnostic requirements for mental disorders in ICD‐11 and DSM‐5	117
Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021	109
The social determinants of mental health and disorder: evidence, prevention and recommendations	107
“Third‐wave” cognitive and behavioral therapies and the emergence of a process‐based approach to intervention in psychiatry	105
The lived experience of psychosis: a bottom‐up review co‐written by experts by experience and academics	102
Candidate biomarkers in psychiatric disorders: state of the field	97
Psychiatric diagnosis and treatment in the 21st century: paradigm shifts versus incremental integration	95
Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review	87
Mental health care for older adults: recent advances and new directions in clinical practice and research	86

Emerging experience with selected new categories in the ICD‐11: complex PTSD, prolonged grief disorder, gaming disorder, and compulsive sexual behaviour disorder	85
Prioritizing COVID‐19 vaccination for people with severe mental illness	84
PHQ‐9: global uptake of a depression scale	83
Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta‐analysis including 409 trials with 52,702 patien	82
Psychological processes mediating the association between developmental trauma and specific psychotic symptoms in adults: a systematic review and meta‐analysis	80
Differential impact of COVID‐related lockdown on mental health in Germany	80
The World Mental Health Report: transforming mental health for all	77
Initial treatment choices to achieve sustained response in major depression: a systematic review and network meta‐analysis	74
A pandemic of social isolation?	72
Therapist‐supported Internet‐based cognitive behaviour therapy yields similar effects as face‐to‐face therapy for psychiatric and somatic disorders: an updated systematic review and meta‐analysis	72
The Horyzons project: a randomized controlled trial of a novel online social therapy to maintain treatment effects from specialist first‐episode psychosis services	71
The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management	71
New insights from the last decade of research in psychiatric genetics: discoveries, challenges and clinical implications	69
The critical distinction between suicidal ideation and suicide attempts	64
Community‐based social interventions for people with severe mental illness: a systematic review and narrative synthesis of recent evidence	62
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents	57
Effectiveness of a WHO self‐help psychological intervention for preventing mental disorders among Syrian refugees in Turkey: a randomized controlled trial	55
The alliance in mental health care: conceptualization, evidence and clinical applications	55
Oral and long‐acting antipsychotics for relapse prevention in schizophrenia‐spectrum disorders: a network meta‐analysis of 92 randomized trials including 22,645 participants	55
Acute psychiatric care: approaches to increasing the range of services and improving access and quality of care	54
Mental health problems among COVID‐19 survivors in Wuhan, China	47
The impact of social network sites on mental health: distinguishing active from passive use	46